1. Stocks
    2. /
  2. Moderna (NASDAQ: MRNA)
    3. /

Moderna (NASDAQ: MRNA) Share Price and News

$36.85 $-2.92 (-7.3%) Saturday, 16 November 2024 at 8:00:00 am Australian Eastern Daylight Time

Moderna Chart and Price Data

About Moderna

Last updated 16-11-2024, 08:00:00am AEDT
Current Price $36.85
Change $-2.92 (-7.3%)
Close Price $36.85
Open Price $38.55
Bid $37.15
Ask $37.29
Day Range $35.80 - $38.70
Year Range $35.80 - $170.47
Volume 24,355,514
Average Volume 6,130,754
Market Cap $14,180,543,300.00
Earnings Per Share $-5.82

    • Moderna (NASDAQ: MRNA)
    Latest News

    Vaccine vials sitting on top of a pile of US cash
    International Stock News

    The most popular coronavirus stock may lose half its value by 2023

    | Sean Williams

    This as-of-now unstoppable COVID-19 stock might be one of the worst investments going forward.

    Read more »

    Doctors and medical specialists look at the results of a drug trial, as the race for a coronavirus vaccine continues
    International Stock News

    Is Moderna stock a hold?

    | Cory Renauer

    An analyst downgrade put one of the year's top-performing stocks under pressure.

    Read more »

    vials of medication labelled with COVID-19 vaccine stickers
    Share Market News

    CSL (ASX:CSL) share price on watch after hints of 'far more robust' vaccine

    | Bernd Struben

    Australian global biotech giant CSL Limited didn't win the sprint for a coronavirus vaccine. But it may lead the marathon.

    Read more »

    travel asx share price represented by suitcase wearing covid mask
    Share Gainers

    Which ASX travel shares performed the best in November? 

    | Lina Lim

    On the back of vaccine hopes and reopening borders, which ASX travel shares performed the best in November? We take…

    Read more »

    doctor holding covid-19 vaccine bottle
    International Stock News

    3 key advantages Moderna holds over Pfizer and AstraZeneca

    | Keith Speights

    They could add up to make Moderna a much bigger winner for investors than either of the two big pharma…

    Read more »

    investor of asx shares holding up hand to say no
    Share Market News

    Why Platinum Asset's healthcare fund doesn't own CSL (ASX:CSL) shares

    | Bernd Struben

    CSL is the fourth largest company trading on the ASX 200. But Platinum Asset's healthcare fund doesn't own any CSL…

    Read more »

    Doctor holding small world globe in one hand and a Covid vaccine needle in the other
    International Stock News

    Why AstraZeneca's potential vaccine is more exciting than you think

    | Jason Hawthorne

    Investors are missing the big picture in the drugmaker's vaccine announcement.

    Read more »

    Cash piled up in the middle of a bear trap symbolising risky investments
    International Stock News

    Why Moderna Is Less Risky Than You Think

    | Manali Bhade

    Its coronavirus vaccine will likely be successful; its technology has huge potential; and the company has a healthy balance sheet.

    Read more »

    small figure representing ASX shares with cape and shield fighting coronavirus
    Share Gainers

    With the Moderna (NASDAQ:MRNA) share price blasting up, have the forward-looking markets got it right?

    | Bernd Struben

    The Moderna (NASDAQ: MRNA) share price is going gangbusters as the world awaits results of its COVID-19 vaccine trial. Let's…

    Read more »

    asx investor daydreaming about US shares
    Share Market News

    Here are the US shares that CommSec customers are buying

    | Sebastian Bowen

    Boeing (NYSE: BA), Pfizer (NYSE: PFE) and Tesla (NASDAQ: TSLA) were among the most traded US shares on the CommSec…

    Read more »

    vials of medication labelled with COVID-19 vaccine stickers
    International Stock News

    Here's why Moderna's coronavirus vaccine could outsell Pfizer's

    | Alex Carchidi

    Moderna's candidate is cool with being kept at warmer temperatures.

    Read more »

    Share Market News

    Dow Jones hits new record highs. Are ASX 200 shares next?

    | Bernd Struben

    The Dow Jones just hit new all-time highs. ASX 200 shares are still 9% below their record highs, but that…

    Read more »

    Profile

    since

    Note